
Worked on the opentargets/gentropy repository, delivering features and improvements for genomic data analysis pipelines. Over six months, contributed to fine-mapping workflows, drug enrichment analytics, and robust statistical calculations, focusing on data integrity and reliability. Applied Python, PySpark, and advanced testing techniques to implement cis-eQTL colocalisation, enhance numerical stability for large-scale statistical models, and expand study-type support for fine-mapping. Strengthened the testing framework with AI-assisted test generation and comprehensive edge-case coverage, ensuring maintainability and reducing regression risk. Collaborated across teams to refine data engineering processes, improve genomic region utilities, and deliver analytics that support evidence-based genetic research.
Month: 2026-02 | Repository: opentargets/gentropy. Focused on strengthening the testing framework for genomic region utilities. Key delivery: Genomic region utilities testing framework enhancement, introducing comprehensive test cases (including edge cases and error handling), updating tests to reflect API changes, removing redundant tests, and applying AI-assisted test generation/refinement to raise quality and maintainability. No major bugs fixed this month; effort centered on test quality and API compatibility. Overall impact: higher test coverage reduces regression risk, accelerates safe releases, and improves reliability of genomic region processing. Technologies/skills demonstrated: advanced testing techniques, AI-assisted test development, API-driven test updates, code quality improvements, and cross-team collaboration.
Month: 2026-02 | Repository: opentargets/gentropy. Focused on strengthening the testing framework for genomic region utilities. Key delivery: Genomic region utilities testing framework enhancement, introducing comprehensive test cases (including edge cases and error handling), updating tests to reflect API changes, removing redundant tests, and applying AI-assisted test generation/refinement to raise quality and maintainability. No major bugs fixed this month; effort centered on test quality and API compatibility. Overall impact: higher test coverage reduces regression risk, accelerates safe releases, and improves reliability of genomic region processing. Technologies/skills demonstrated: advanced testing techniques, AI-assisted test development, API-driven test updates, code quality improvements, and cross-team collaboration.
November 2025: Delivered Drug Enrichment Analysis Enhancement in opentargets/gentropy, introducing a new DrugEnrichmentAnalysis class to compute and report drug target enrichment statistics. The feature includes edge-case handling for division by zero and adds relative success metrics to improve interpretability of results. This work strengthens evidence-based assessment of drug efficacy and improves the analytics workflow.
November 2025: Delivered Drug Enrichment Analysis Enhancement in opentargets/gentropy, introducing a new DrugEnrichmentAnalysis class to compute and report drug target enrichment statistics. The feature includes edge-case handling for division by zero and adds relative success metrics to improve interpretability of results. This work strengthens evidence-based assessment of drug efficacy and improves the analytics workflow.
Month 2025-10: Strengthened the fine-mapping workflow in opentargets/gentropy by expanding study-type support, tightening parameter handling, and hardening error paths. Focused delivery on broader applicability for downstream analyses and improved robustness for diverse study designs.
Month 2025-10: Strengthened the fine-mapping workflow in opentargets/gentropy by expanding study-type support, tightening parameter handling, and hardening error paths. Focused delivery on broader applicability for downstream analyses and improved robustness for diverse study designs.
June 2025: Focused on numerical robustness in opentargets/gentropy. Implemented an approximation for z2 > 1400 within neglogpval_from_z2 to address precision issues for very large z2, improving robustness of statistical calculations and reliability of downstream analyses. This change reduces edge-case failures in high-magnitude inputs and strengthens trust in p-value transformations used for genomic targeting analytics. The work aligns with stability, testing, and maintainability goals and complements existing quality controls across the repository.
June 2025: Focused on numerical robustness in opentargets/gentropy. Implemented an approximation for z2 > 1400 within neglogpval_from_z2 to address precision issues for very large z2, improving robustness of statistical calculations and reliability of downstream analyses. This change reduces edge-case failures in high-magnitude inputs and strengthens trust in p-value transformations used for genomic targeting analytics. The work aligns with stability, testing, and maintainability goals and complements existing quality controls across the repository.
May 2025 performance summary for opentargets/gentropy focused on delivering a robust cis-eQTL colocalisation feature extraction and improving data quality for gene-feature matrices. Implemented cis-eQTL filtering in Colocalisation logic, and corrected isProteinCoding flag derivation to align with biotype data, resulting in more reliable downstream analyses and updated test coverage. The work strengthens business value by reducing false positives in colocalisation features and improving accuracy of protein-coding gene identification.
May 2025 performance summary for opentargets/gentropy focused on delivering a robust cis-eQTL colocalisation feature extraction and improving data quality for gene-feature matrices. Implemented cis-eQTL filtering in Colocalisation logic, and corrected isProteinCoding flag derivation to align with biotype data, resulting in more reliable downstream analyses and updated test coverage. The work strengthens business value by reducing false positives in colocalisation features and improving accuracy of protein-coding gene identification.
Month: 2024-11 — Focused on data integrity and correctness in the opentargets/gentropy pipeline. Delivered targeted bug fixes that improve the accuracy of imputation and LD calculations, enabling more reliable downstream analyses and better decision-making for genetic data interpretation. These changes reduce data processing variance and simplify QC.
Month: 2024-11 — Focused on data integrity and correctness in the opentargets/gentropy pipeline. Delivered targeted bug fixes that improve the accuracy of imputation and LD calculations, enabling more reliable downstream analyses and better decision-making for genetic data interpretation. These changes reduce data processing variance and simplify QC.

Overview of all repositories you've contributed to across your timeline